Welcome to the Hope Bio Blog

By Jan Shultis, Ph.D. In 2023, Texas-based biopharmaceutical company Hope Biosciences cultured approximately 170 billion adult stem cells for use in dozens of disease and injury conditions, including in 18 FDA-authorized research protocols. It was a year that saw a new volume of peer-reviewed publications, conference presentations, and community engagements. Also in 2023, Hope Biosciences increasingly became a household name in skincare, with a partner’s very public launch of

By Jan Shultis, Ph.D. At Hope Biosciences, we culture every one of your stem cells by hand. This work matters to us as a strategy for sustainable customized medicine in the United States, as a biotechnology solution to health problems plaguing our communities, and on a very personal level as service to individuals who trust us with their stem cells. A glimpse into Leo's life. Personal caring is, we believe, the essence of translational medicine (“translational medicine” can

A conversation about medical usefulness, money, and health in individual families By Jan Shultis, Ph.D. Cord blood banking is the practice of preserving the blood found in a baby’s umbilical cord at birth, with the intention that the hematopoietic stem cells found in cord blood could one day be used to create stem cell treatments, should that newborn be diagnosed with a blood-based disease or condition. Umbilical cord blood stem cells have been used in treatment since the fir